Video

Dr Robert A. Gabbay Calls for a Shift in Diabetes Care Models

CMS' shift to value-based payments has also shifted diabetes care models from cost-centered systems to cost-savings centers, according to Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center.

CMS’ shift to value-based payments has also shifted diabetes care models from cost-centered systems to cost-savings centers, according to Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center and editor-in-chief of Evidence-Based Diabetes Management.

He added that traditionally, many health systems look to recoup lost investments through procedure revenues; however, physicians ideally want to prevent these future complications and surgeries. Dr Gabbay suggested that the cost-savings system is a way to achieve this goal.

“If you’re going to control overall costs of diabetes, you’ve got to decrease long-term complications and therefore invest in the things that we already know that work,” he said.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Carrie Kitko
Merrill H. Stewart, MD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Dr Ibrahim Aldoss
Jody Agena, PharmD, MBA, director of pharamcy operations, Virginia Cancer Specialists
Rachel Rohaidy, MD
Mansi Shah, MD
Miriam Freimer, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo